Identification of estrogen responsive genes using esophageal squamous cell carcinoma (ESCC) as a model

BMC Systems Biology

Volumn 6, Issue , 2012, Pages

  Essack, Magbubah ^a   MacPherson, Cameron R ^a   Schmeier, Sebastian ^a   Bajic, Vladimir B ^a  

^a KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; TRANSCRIPTION FACTOR;

ARTICLE; BINDING SITE; DNA RESPONSIVE ELEMENT; DRUG EFFECT; ESOPHAGUS TUMOR; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; METABOLISM; METHODOLOGY; PROTEIN TRANSPORT; SQUAMOUS CELL CARCINOMA; SYSTEMS BIOLOGY;

BINDING SITES; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; ESTROGENS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PROTEIN TRANSPORT; RESPONSE ELEMENTS; SYSTEMS BIOLOGY; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 84867766830     PISSN: None     EISSN: 17520509     Source Type: Journal    
DOI: 10.1186/1752-0509-6-135     Document Type: Article

References (71)

1. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 1993, 54(4):594-606. 10.1002/ijc.2910540413, 8514451.
2. Pisani P, Parkin DM, Ferlay J. Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden. Int J Cancer 1993, 55(6):891-903. 10.1002/ijc.2910550604, 8253525.
3. Reed CE. Surgical management of esophageal carcinoma. Oncologist 1999, 4(2):95-105.
4. Stoner GDRA. Biology of the esophageal squamous cell carcinoma. Gastrointest Cancers Biol Diagn 1995, 8:141-146.
5. Siewert JR, Ott K. Are squamous and adenocarcinomas of the esophagus the same disease?. Semin Radiat Oncol 2007, 17(1):38-44. 10.1016/j.semradonc.2006.09.007, 17185196.
6. Bodelon C, Anderson GL, Rossing MA, Chlebowski RT, Ochs-Balcom HM, Vaughan TL. Hormonal factors and risks of esophageal squamous cell carcinoma and adenocarcinoma in postmenopausal women. Cancer Prev Res (Phila) 2011, 4(6):840-850.
7. Nozoe T, Oyama T, Takenoyama M, Hanagiri T, Sugio K, Yasumoto K. Significance of immunohistochemical expression of estrogen receptors alpha and beta in squamous cell carcinoma of the esophagus. Clin Cancer Res 2007, 13(14):4046-4050. 10.1158/1078-0432.CCR-07-0449, 17634528.
8. Ueo H, Matsuoka H, Sugimachi K, Kuwano H, Mori M, Akiyoshi T. Inhibitory effects of estrogen on the growth of a human esophageal carcinoma cell line. Cancer Res 1990, 50(22):7212-7215.
9. Utsumi Y, Nakamura T, Nagasue N, Kubota H, Morikawa S. Role of estrogen receptors in the growth of human esophageal carcinoma. Cancer 1989, 64(1):88-93. 10.1002/1097-0142(19890701)64:1<88::AID-CNCR2820640116>3.0.CO;2-4, 2731125.
10. Kambhampati S, Banerjee S, Dhar K, Mehta S, Haque I, Dhar G, Majumder M, Ray G, Vanveldhuizen PJ, Banerjee SK. 2-methoxyestradiol inhibits Barrett's esophageal adenocarcinoma growth and differentiation through differential regulation of the beta-catenin-E-cadherin axis. Mol Cancer Ther 2010, 9(3):523-534. 10.1158/1535-7163.MCT-09-0845, 2837538, 20197389.
11. Wang QM, Qi YJ, Jiang Q, Ma YF, Wang LD. Relevance of serum estradiol and estrogen receptor beta expression from a high-incidence area for esophageal squamous cell carcinoma in China. Med Oncol 2011, 28(1):188-193. 10.1007/s12032-010-9457-8, 20195802.
12. Rashid F, Khan RN, Iftikhar SY. Probing the link between oestrogen receptors and oesophageal cancer. World J Surg Oncol 2010, 8:9. 10.1186/1477-7819-8-9, 2831901, 20146809.
13. Wang QM, Yuan L, Qi YJ, Ma ZY, Wang LD. Estrogen analogues: promising target for prevention and treatment of esophageal squamous cell carcinoma in high risk areas. Medical science monitor: international medical journal of experimental and clinical research 2010, 16(7):HY19-HY22.
14. Klinge CM. Estrogen receptor interaction with estrogen response elements. Nucleic Acids Res 2001, 29(14):2905-2919. 10.1093/nar/29.14.2905, 55815, 11452016.
15. Pettersson K, Grandien K, Kuiper GG, Gustafsson JA. Mouse estrogen receptor beta forms estrogen response element-binding heterodimers with estrogen receptor alpha. Mol Endocrinol 1997, 11(10):1486-1496. 10.1210/me.11.10.1486, 9280064.
16. Menasce LP, White GR, Harrison CJ, Boyle JM. Localization of the estrogen receptor locus (ESR) to chromosome 6q25.1 by FISH and a simple post-FISH banding technique. Genomics 1993, 17(1):263-265. 10.1006/geno.1993.1320, 8406468.
17. Enmark E, Pelto-Huikko M, Grandien K, Lagercrantz S, Lagercrantz J, Fried G, Nordenskjold M, Gustafsson JA. Human estrogen receptor beta-gene structure, chromosomal localization, and expression pattern. J Clin Endocrinol Metab 1997, 82(12):4258-4265. 10.1210/jc.82.12.4258, 9398750.
18. Hyder SM, Chiappetta C, Stancel GM. Interaction of human estrogen receptors alpha and beta with the same naturally occurring estrogen response elements. Biochem Pharmacol 1999, 57(6):597-601. 10.1016/S0006-2952(98)00355-4, 10037443.
19. Liu MM, Albanese C, Anderson CM, Hilty K, Webb P, Uht RM, Price RH, Pestell RG, Kushner PJ. Opposing action of estrogen receptors alpha and beta on cyclin D1 gene expression. J Biol Chem 2002, 277(27):24353-24360. 10.1074/jbc.M201829200, 11986316.
20. Hayashi SI, Eguchi H, Tanimoto K, Yoshida T, Omoto Y, Inoue A, Yoshida N, Yamaguchi Y. The expression and function of estrogen receptor alpha and beta in human breast cancer and its clinical application. Endocr Relat Cancer 2003, 10(2):193-202. 10.1677/erc.0.0100193, 12790782.
21. Onita T, Igawa T, Hisamatsu H, Sakai H, Kanetake H. Secondary endocrine therapy with oral estrogen for relapsed prostate cancer. Hinyokika Kiyo 2009, 55(10):595-598.
22. Wang PH, Wang HC, Tsai CC. Estrogen replacement in female lung cancer during gefitinib therapy. Jpn J Clin Oncol 2009, 39(12):829-832. 10.1093/jjco/hyp096, 19692419.
23. Morgan RJ, Synold T, Mamelak A, Lim D, Al-Kadhimi Z, Twardowski P, Leong L, Chow W, Margolin K, Shibata S, et al. Plasma and cerebrospinal fluid pharmacokinetics of topotecan in a phase I trial of topotecan, tamoxifen, and carboplatin, in the treatment of recurrent or refractory brain or spinal cord tumors. Cancer Chemother Pharmacol 2010, 66(5):927-933. 10.1007/s00280-010-1242-z, 3265324, 20107803.
24. Douglas M. The treatment of advanced breast cancer by hormone therapy. Br J Cancer 1952, 6(1):32-45. 10.1038/bjc.1952.4, 2007823, 14925266.
25. Bajic VB, Tan SL, Chong A, Tang S, Strom A, Gustafsson JA, Lin CY, Liu ET. Dragon ERE Finder version 2: A tool for accurate detection and analysis of estrogen response elements in vertebrate genomes. Nucleic Acids Res 2003, 31(13):3605-3607. 10.1093/nar/gkg517, 168924, 12824376.
26. Tang S, Zhang Z, Tan SL, Tang MH, Kumar AP, Ramadoss SK, Bajic VB. KBERG: KnowledgeBase for estrogen responsive genes. Nucleic Acids Res 2007, 35(Database issue):D732-D736. 1669744, 17090589.
27. Jin VX, Sun H, Pohar TT, Liyanarachchi S, Palaniswamy SK, Huang TH, Davuluri RV. ERTargetDB: an integral information resource of transcription regulation of estrogen receptor target genes. J Mol Endocrinol 2005, 35(2):225-230. 10.1677/jme.1.01839, 16216904.
28. Essack M, Radovanovic A, Schaefer U, Schmeier S, Seshadri SV, Christoffels A, Kaur M, Bajic VB. DDEC: Dragon database of genes implicated in esophageal cancer. BMC Cancer 2009, 9:219. 10.1186/1471-2407-9-219, 2711974, 19580656.
29. Carninci P, Kasukawa T, Katayama S, Gough J, Frith MC, Maeda N, Oyama R, Ravasi T, Lenhard B, Wells C, et al. The transcriptional landscape of the mammalian genome. Science 2005, 309(5740):1559-1563.
30. Kel AE, Gossling E, Reuter I, Cheremushkin E, Kel-Margoulis OV, Wingender E. MATCH: A tool for searching transcription factor binding sites in DNA sequences. Nucleic Acids Res 2003, 31(13):3576-3579. 10.1093/nar/gkg585, 169193, 12824369.
31. Matys V, Kel-Margoulis OV, Fricke E, Liebich I, Land S, Barre-Dirrie A, Reuter I, Chekmenev D, Krull M, Hornischer K, et al. TRANSFAC and its module TRANSCompel: transcriptional gene regulation in eukaryotes. Nucleic Acids Res 2006, 34(Database issue):D108-D110. 1347505, 16381825.
32. Wingender E, Chen X, Fricke E, Geffers R, Hehl R, Liebich I, Krull M, Matys V, Michael H, Ohnhauser R, et al. The TRANSFAC system on gene expression regulation. Nucleic Acids Res 2001, 29(1):281-283. 10.1093/nar/29.1.281, 29801, 11125113.
33. Saeed AI, Sharov V, White J, Li J, Liang W, Bhagabati N, Braisted J, Klapa M, Currier T, Thiagarajan M, et al. TM4: a free, open-source system for microarray data management and analysis. Biotechniques 2003, 34(2):374-378.
34. Saeed AI, Bhagabati NK, Braisted JC, Liang W, Sharov V, Howe EA, Li J, Thiagarajan M, White JA, Quackenbush J. TM4 microarray software suite. Methods Enzymol 2006, 411:134-193.
35. Choi HJ, Chung YS, Kim HJ, Moon UY, Choi YH, Van Seuningen I, Baek SJ, Yoon HG, Yoon JH. Signal pathway of 17beta-estradiol-induced MUC5B expression in human airway epithelial cells. Am J Respir Cell Mol Biol 2009, 40(2):168-178.
36. Grandas OH, Mountain DH, Kirkpatrick SS, Cassada DC, Stevens SL, Freeman MB, Goldman MH. Regulation of vascular smooth muscle cell expression and function of matrix metalloproteinases is mediated by estrogen and progesterone exposure. J Vasc Surg 2009, 49(1):185-191. 10.1016/j.jvs.2008.07.080, 18829229.
37. Varea O, Garrido JJ, Dopazo A, Mendez P, Garcia-Segura LM, Wandosell F. Estradiol activates beta-catenin dependent transcription in neurons. PLoS One 2009, 4(4):e5153. 10.1371/journal.pone.0005153, 2664482, 19360103.
38. Pechenino AS, Frick KM. The effects of acute 17beta-estradiol treatment on gene expression in the young female mouse hippocampus. Neurobiol Learn Mem 2009, 91(3):315-322. 10.1016/j.nlm.2008.09.017, 2674265, 18938255.
39. Lai JC, Wu JY, Cheng YW, Yeh KT, Wu TC, Chen CY, Lee H. O6-Methylguanine-DNA methyltransferase hypermethylation modulated by 17beta-estradiol in lung cancer cells. Anticancer Res 2009, 29(7):2535-2540.
40. Ochsner SA, Steffen DL, Hilsenbeck SG, Chen ES, Watkins C, McKenna NJ. GEMS (Gene Expression MetaSignatures), a Web resource for querying meta-analysis of expression microarray datasets: 17beta-estradiol in MCF-7 cells. Cancer Res 2009, 69(1):23-26. 10.1158/0008-5472.CAN-08-3492, 2782370, 19117983.
41. Hayashi K, Erikson DW, Tilford SA, Bany BM, Maclean JA, Rucker EB, Johnson GA, Spencer TE. Wnt genes in the mouse uterus: potential regulation of implantation. Biol Reprod 2009, 80(5):989-1000. 10.1095/biolreprod.108.075416, 2804842, 19164167.
42. Fernandez SV, Russo J. Estrogen and xenoestrogens in breast cancer. Toxicol Pathol 2010, 38(1):110-122. 10.1177/0192623309354108, 2907875, 19933552.
43. Baltgalvis KA, Greising SM, Warren GL, Lowe DA. Estrogen regulates estrogen receptors and antioxidant gene expression in mouse skeletal muscle. PLoS One 2010, 5(4):e10164. 10.1371/journal.pone.0010164, 2854140, 20405008.
44. Lam SH, Lee SG, Lin CY, Thomsen JS, Fu PY, Murthy KR, Li H, Govindarajan KR, Nick LC, Bourque G, et al. Molecular conservation of estrogen-response associated with cell cycle regulation, hormonal carcinogenesis and cancer in zebrafish and human cancer cell lines. BMC Med Genomics 2011, 4:41. 10.1186/1755-8794-4-41, 3114699, 21575170.
45. Weiss MS, Penalver Bernabe B, Bellis AD, Broadbelt LJ, Jeruss JS, Shea LD. Dynamic, large-scale profiling of transcription factor activity from live cells in 3D culture. PLoS One 2010, 5(11):e14026. 10.1371/journal.pone.0014026, 2984444, 21103341.
46. Abbondanza C, De Rosa C, D'Arcangelo A, Pacifico M, Spizuoco C, Piluso G, Di Zazzo E, Gazzerro P, Medici N, Moncharmont B, et al. Identification of a functional estrogen-responsive enhancer element in the promoter 2 of PRDM2 gene in breast cancer cell lines. J Cell Physiol 2012, 227(3):964-975. 10.1002/jcp.22803, 21503890.
47. Brekman A, Singh KE, Polotskaia A, Kundu N, Bargonetti J. A p53-independent role of Mdm2 in estrogen-mediated activation of breast cancer cell proliferation. Breast Cancer Res 2011, 13(1):R3. 10.1186/bcr2804, 3109566, 21223569.
48. Pechenino AS, Lin L, Mbai FN, Lee AR, He XM, Stallone JN, Knowlton AA. Impact of aging vs. Estrogen loss on cardiac gene expression: estrogen replacement and inflammation. Physiol Genomics 2011, 43(18):1065-1073. 10.1152/physiolgenomics.00228.2010, 3180739, 21750230.
49. Carroll JS, Liu XS, Brodsky AS, Li W, Meyer CA, Szary AJ, Eeckhoute J, Shao W, Hestermann EV, Geistlinger TR, et al. Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell 2005, 122(1):33-43. 10.1016/j.cell.2005.05.008, 16009131.
50. Bourdeau V, Deschenes J, Metivier R, Nagai Y, Nguyen D, Bretschneider N, Gannon F, White JH, Mader S. Genome-wide identification of high-affinity estrogen response elements in human and mouse. Mol Endocrinol 2004, 18(6):1411-1427. 10.1210/me.2003-0441, 15001666.
51. McKenna NJ, O'Malley BW. Combinatorial control of gene expression by nuclear receptors and coregulators. Cell 2002, 108(4):465-474. 10.1016/S0092-8674(02)00641-4, 11909518.
52. Eisermann K, Tandon S, Bazarov A, Brett A, Fraizer G, Piontkivska H. Evolutionary conservation of zinc finger transcription factor binding sites in promoters of genes co-expressed with WT1 in prostate cancer. BMC Genomics 2008, 9:337. 10.1186/1471-2164-9-337, 2515153, 18631392.
53. Ikeda K, Kawakami K. DNA binding through distinct domains of zinc-finger-homeodomain protein AREB6 has different effects on gene transcription. Eur J Biochem 1995, 233(1):73-82. 10.1111/j.1432-1033.1995.073_1.x, 7588776.
54. Cheng L, Li L, Qiao X, Liu J, Yao X. Functional characterization of the promoter of human kinetochore protein HEC1: novel link between regulation of the cell cycle protein and CREB family transcription factors. Biochim Biophys Acta 2007, 1769(9-10):593-602.
55. Paca-Uccaralertkun S, Zhao LJ, Adya N, Cross JV, Cullen BR, Boros IM, Giam CZ. In vitro selection of DNA elements highly responsive to the human T-cell lymphotropic virus type I transcriptional activator, Tax. Mol Cell Biol 1994, 14(1):456-462. 358395, 8264613.
56. Singh M, Spoelstra NS, Jean A, Howe E, Torkko KC, Clark HR, Darling DS, Shroyer KR, Horwitz KB, Broaddus RR, et al. ZEB1 expression in type I vs type II endometrial cancers: a marker of aggressive disease. Mod Pathol 2008, 21(7):912-923. 10.1038/modpathol.2008.82, 18487993.
57. Linnerth NM, Greenaway JB, Petrik JJ, Moorehead RA. cAMP response element-binding protein is expressed at high levels in human ovarian adenocarcinoma and regulates ovarian tumor cell proliferation. Int J Gynecol Cancer 2008, 18(6):1248-1257. 10.1111/j.1525-1438.2007.01177.x, 18554190.
58. Khoury T, Chadha K, Javle M, Donohue K, Levea C, Iyer R, Okada H, Nagase H, Tan D. Expression of intestinal trefoil factor (TFF-3) in hepatocellular carcinoma. Int J Gastrointest Cancer 2005, 35(3):171-177. 10.1385/IJGC:35:3:171, 16110118.
59. Zhang J, Kalkum M, Yamamura S, Chait BT, Roeder RG. E protein silencing by the leukemogenic AML1-ETO fusion protein. Science 2004, 305(5688):1286-1289. 10.1126/science.1097937, 15333839.
60. Adachi Y, Takeuchi T, Nagayama T, Ohtsuki Y, Furihata M. Zeb1-mediated T-cadherin repression increases the invasive potential of gallbladder cancer. FEBS Lett 2009, 583(2):430-436. 10.1016/j.febslet.2008.12.042, 19116147.
61. Roy K, de la Serna IL, Imbalzano AN. The myogenic basic helix-loop-helix family of transcription factors shows similar requirements for SWI/SNF chromatin remodeling enzymes during muscle differentiation in culture. J Biol Chem 2002, 277(37):33818-33824. 10.1074/jbc.M205159200, 12105204.
62. Kibler KV, Jeang KT. CREB/ATF-dependent repression of cyclin a by human T-cell leukemia virus type 1 Tax protein. J Virol 2001, 75(5):2161-2173. 10.1128/JVI.75.5.2161-2173.2001, 114800, 11160720.
63. Breitkreutz BJ, Stark C, Reguly T, Boucher L, Breitkreutz A, Livstone M, Oughtred R, Lackner DH, Bahler J, Wood V, et al. The BioGRID interaction database: 2008 update. Nucleic Acids Res 2008, 36(Database issue):D637-D640. 2238873, 18000002.
64. Rubino D, Driggers P, Arbit D, Kemp L, Miller B, Coso O, Pagliai K, Gray K, Gutkind S, Segars J. Characterization of Brx, a novel Dbl family member that modulates estrogen receptor action. Oncogene 1998, 16(19):2513-2526. 10.1038/sj.onc.1201783, 9627117.
65. Kino T, Souvatzoglou E, Charmandari E, Ichijo T, Driggers P, Mayers C, Alatsatianos A, Manoli I, Westphal H, Chrousos GP, et al. Rho family Guanine nucleotide exchange factor Brx couples extracellular signals to the glucocorticoid signaling system. J Biol Chem 2006, 281(14):9118-9126.
66. Driggers PH, Segars JH, Rubino DM. The proto-oncoprotein Brx activates estrogen receptor beta by a p38 mitogen-activated protein kinase pathway. J Biol Chem 2001, 276(50):46792-46797. 10.1074/jbc.M106927200, 11579095.
67. Faried A, Faried LS, Kimura H, Nakajima M, Sohda M, Miyazaki T, Kato H, Usman N, Kuwano H. RhoA and RhoC proteins promote both cell proliferation and cell invasion of human oesophageal squamous cell carcinoma cell lines in vitro and in vivo. Eur J Cancer 2006, 42(10):1455-1465. 10.1016/j.ejca.2006.02.012, 16750623.
68. Dennis G, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol 2003, 4(5):P3. 10.1186/gb-2003-4-5-p3, 12734009.
69. Ma ZQ, Liu Z, Ngan ES, Tsai SY. Cdc25B functions as a novel coactivator for the steroid receptors. Mol Cell Biol 2001, 21(23):8056-8067. 10.1128/MCB.21.23.8056-8067.2001, 99972, 11689696.
70. Mehta CR, Patel NR. Algorithm 643. FEXACT: A Fortran subroutine for fisher's exact test on unordered rxc contingency tables. ACM Trans Math Softw 1986, 12(2):154-161.
71. Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I. Controlling the false discovery rate in behavior genetics research. Behavioural brain research 2001, 125(1-2):279-284.